Spire Wealth Management Vaxxinity, Inc. Transaction History

Spire Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$0.05 - $0.71 $7,640 - $108,492	152,807 Added 1703.72%	161,776 $40,000
Q1 2024 Apr 24, 2024	SELL	$0.62 - $0.86 $6,191 - $8,587	-9,986 Reduced 52.68%	8,969 $6,000
Q4 2023 Feb 06, 2024	BUY	$0.7 - $1.31 $13,268 - $24,831	18,955 New	18,955 $16,000
Q1 2023 May 09, 2023	BUY	$1.43 - $4.24 $2,145 - $6,360	1,500 New	1,500 $3,000

287K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Market Cap $1.12M
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.